![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
BA Domin, SP Grill, KF Bastow and YC Cheng
A cloned subline of human cell variants derived from KB cells (KB/6b), 6500-fold resistant to methotrexate (MTX), exhibited a stable 40-fold elevation of the enzyme dihydrofolate reductase (EC 1.5.1.3., DHFR) in the absence of the drug. No differences were detected between the enzyme isolated from resistant and parental KB cells. After the culture medium was supplemented with MTX, the resistant cells were shown to have an additional 5-fold increase in DHFR levels. This increment was dependent upon the concentration of exogenous MTX and was freely reversible. This behavior differs from that of other DHFR-overproducing mammalian cell lines previously reported. The half-life of DHFR in these cells in the presence or absence of MTX was the same, thus eliminating stabilization of the enzyme by MTX as being responsible for the modulation or "induction" phenomenon. Furthermore, the effect was blocked by cycloheximide and was not affected by actinomycin D. These results suggest that modulation of DHFR specific activity by MTX occurs at either the translational level or by as yet undefined post- transcriptional mechanism(s).
This article has been cited by other articles:
|
|
 |
|
  X. Xu, M. D Gammon, J. G Wetmur, M. Rao, M. M Gaudet, S. L Teitelbaum, J. A Britton, A. I Neugut, R. M Santella, and J. Chen A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1098 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Skacel, L. G. Menon, P. J. Mishra, R. Peters, D. Banerjee, J. R. Bertino, and E. E. Abali Identification of Amino Acids Required for the Functional Up-regulation of Human Dihydrofolate Reductase Protein in Response to Antifolate Treatment J. Biol. Chem., June 17, 2005; 280(24): 22721 - 22731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Magro, A. J. Russo, W.-W. Li, D. Banerjee, and J. R. Bertino p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53 Cancer Res., June 15, 2004; 64(12): 4338 - 4345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tai, Y. Ding, J. C. Schmitz, and E. Chu Identification of critical amino acid residues on human dihydrofolate reductase protein that mediate RNA recognition Nucleic Acids Res., October 15, 2002; 30(20): 4481 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mayer-Kuckuk, D. Banerjee, S. Malhotra, M. Doubrovin, M. Iwamoto, T. Akhurst, J. Balatoni, W. Bornmann, R. Finn, S. Larson, et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression PNAS, March 19, 2002; 99(6): 3400 - 3405. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
